Navigation Links
New FTMS System From Varian, Inc. Offers Switchable LC and GC Sources and True Triple Quadrupole Capabilities

NEW ORLEANS, March 3 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new 920-MS Triple Quadrupole Fourier Transform Mass Spectrometer (TQ-FTMS), available with both LC (liquid chromatography) and GC (gas chromatography) interfaces for ionization. The ultra-high resolution (>1,000,000) and mass accuracy (<0.5 ppm) of these instruments provide detailed information to chemists in application areas including proteomics, metabolomics, petrochemical and environmental analyses.

The new 920-MS combines the technology of the proven Varian 320-MS triple quadrupole mass spectrometer with Varian FT-ICR (Ion Cyclotron Resonance) detectors. The available field strengths include 7, 9.4, 12.0 and now 15.0 Tesla -- the highest field commercially available in an FTMS magnet, providing the largest sample dynamic range of any FTMS system. The magnets are available both in conventional and zero boil-off design. A choice of magnets and ionization sources allows customers to configure a solution to meet their specific needs with respect to sensitivity, mass accuracy, dynamic range, and application area.

The system takes advantage of Varian's expertise in LC/MS and GC/MS by incorporating a true triple quadrupole mass spectrometer with its own off axis ion detector independent of the FT cell in the magnet. The choice of two detectors enables users to gather more types of information with a single instrument. In addition to the high resolution and mass accuracy available from the FT detector, users can acquire data from typical triple quadrupole experiments such as neutral loss, multiple reaction monitoring and quantitation.

Historically, FTMS has been primarily used in conjunction with liquid chromatography. The switchable LC/GC interface for the ionization source lets users perform either type of analysis in the same laboratory. The 920-MS employs a unique isolation valve (patent pending) that allows rapid changing (e.g. GC to LC) or maintenance of ion sources without the long down time required when venting the ultra high vacuum FTMS portion of the system to atmospheric pressure. A unique dual cart design is available on the 920-MS. This accommodates multiple instrument configurations, including electrospray and MALDI, with a single magnet.

"The integration of a Varian triple quadrupole mass spectrometer into our existing FTMS system delivers truly information-rich detection to our customers," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "We have combined our technologies to provide scientists with more experimental choices and capabilities in a single instrument."

For more technical information about Varian's FTMS instrumentation, please visit

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site:

For More Information, Contact:

Public Relations

Varian, Inc.


SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
2. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
3. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
4. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
5. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
6. Immune system protein starves staph bacteria
7. PLC Systems to Present at the ROTH Conference
8. AGI Dermatics Clinical Data Identifies L-Ergothioneine as Part of Skins Natural Antioxidant System
9. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
10. AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
11. BioHorizons Announces Agreement to Purchase Implant Logic Systems
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
Breaking Biology Technology:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):